Debt-to-equity of Medpace Holdings, Inc. from 30 Jun 2017 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Medpace Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2017 to 31 Dec 2025.
Medpace Holdings, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 374%, a 147% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Medpace Holdings, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	374%	+222%	+147%	31 Dec 2025
Q3 2025	288%	+129%	+81%	30 Sep 2025
Q2 2025	210%	+31%	+18%	30 Jun 2025
Q1 2025	161%	-42%	-21%	31 Mar 2025
Q4 2024	151%	-85%	-36%	31 Dec 2024
Q3 2024	159%	-94%	-37%	30 Sep 2024
Q2 2024	178%	-94%	-34%	30 Jun 2024
Q1 2024	203%	-91%	-31%	31 Mar 2024
Q4 2023	236%	+7.5%	+3.3%	31 Dec 2023
Q3 2023	254%	+96%	+61%	30 Sep 2023
Q2 2023	272%	+157%	+136%	30 Jun 2023
Q1 2023	295%	+212%	+255%	31 Mar 2023
Q4 2022	229%	+156%	+214%	31 Dec 2022
Q3 2022	158%	+85%	+118%	30 Sep 2022
Q2 2022	115%	+46%	+66%	30 Jun 2022
Q1 2022	83%	+15%	+22%	31 Mar 2022
Q4 2021	73%	+7.6%	+12%	31 Dec 2021
Q3 2021	72%	+11%	+18%	30 Sep 2021
Q2 2021	70%	+10%	+17%	30 Jun 2021
Q1 2021	68%	+11%	+20%	31 Mar 2021
Q4 2020	65%	+8.2%	+14%	31 Dec 2020
Q3 2020	61%	+3%	+5.1%	30 Sep 2020
Q2 2020	59%	-2.6%	-4.2%	30 Jun 2020
Q1 2020	56%	-11%	-17%	31 Mar 2020
Q4 2019	57%	-17%	-23%	31 Dec 2019
Q3 2019	58%	-22%	-27%	30 Sep 2019
Q2 2019	62%	-20%	-24%	30 Jun 2019
Q1 2019	68%	-8%	-11%	31 Mar 2019
Q4 2018	74%	+6.6%	+9.7%	31 Dec 2018
Q3 2018	81%	+19%	+31%	30 Sep 2018
Q2 2018	82%	+23%	+39%	30 Jun 2018
Q1 2018	76%			31 Mar 2018
Q4 2017	68%			31 Dec 2017
Q3 2017	61%			30 Sep 2017
Q2 2017	59%			30 Jun 2017

* An asterisk sign (*) next to the value indicates that the value is likely invalid.